Omega-3 & Pulmonary Fibrosis: Hope for Slowing Disease
- Omega-3 fatty acids, known for thier heart-healthy benefits, may also play a role in slowing the progression of pulmonary fibrosis, a potentially deadly lung-scarring disease.
- The study, which examined data from over 300 individuals with interstitial lung disease, revealed that increased levels of omega-3 fatty acids in blood plasma correlated with better lung...
- Pulmonary fibrosis, a type of interstitial lung disease, impairs the lungs' ability to exchange oxygen and carbon dioxide, leading to shortness of breath and weakness.
Researchers have discovered a promising link: omega-3 fatty acids may significantly impact the progression of pulmonary fibrosis, a serious lung disease. A new UVA study reveals that increased omega-3 levels correlate with improved lung function adn potentially delay the need for lung transplants in affected individuals. This impactful research suggests that omega-3s could be a targetable risk factor, offering hope for better patient outcomes. The study examined over 300 individuals with interstitial lung disease, demonstrating that higher levels of omega-3s in blood plasma correlate to increased survival rates without a lung transplant. Further investigation is planned to determine the specific mechanisms and create clinical trials to explore whether nutritional interventions might improve conditions. we at News Directory 3 are following this closely. Discover whatS next as scientists work on identifying the most beneficial omega-3 types and their effects.
Omega-3 Fatty Acids May Improve Pulmonary Fibrosis Outcomes
Updated June 23, 2025
Omega-3 fatty acids, known for thier heart-healthy benefits, may also play a role in slowing the progression of pulmonary fibrosis, a potentially deadly lung-scarring disease. Researchers at the University of Virginia (UVA) have found a link between higher levels of omega-3s and improved outcomes for patients with this condition.
The study, which examined data from over 300 individuals with interstitial lung disease, revealed that increased levels of omega-3 fatty acids in blood plasma correlated with better lung function and longer survival without requiring a lung transplant. The findings held true regardless of smoking history or cardiovascular disease.
Pulmonary fibrosis, a type of interstitial lung disease, impairs the lungs’ ability to exchange oxygen and carbon dioxide, leading to shortness of breath and weakness. Smoking is a major risk factor.
Dr.John Kim, a pulmonary and critical care expert at UVA Health, said the research suggests that “omega-3 fatty acids might be a targetable risk factor in pulmonary fibrosis.”
Kim added,”Higher levels of omega-3 fatty acids were predictive of better clinical outcomes in pulmonary fibrosis.”
while the study highlights a promising association, researchers emphasize the need for further examination to fully understand the protective mechanisms of omega-3s. They are advocating for clinical trials to determine if interventions, such as dietary changes or omega-3 supplements, can improve outcomes for patients with pulmonary fibrosis and other chronic lung diseases.
What’s next
Future research will focus on identifying specific omega-3 fatty acids that offer the most benefit and exploring their underlying mechanisms. The goal is to determine if nutrition-related interventions can positively impact pulmonary fibrosis, similar to other chronic diseases.